Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
Not all profitable companies are created equal, and that’s why we built StockStory - to help you find the ones that truly shine bright. Keeping that in mind, here is one profitable company that leverages its financial strength to beat the competition and two best left off your watchlist.
Two Stocks to Sell:
Veralto (VLTO)
Trailing 12-Month GAAP Operating Margin: 22.7%
Spun off from Danaher in 2023, Veralto (NYSE: VLTO) provides water analytics and treatment solutions.
Why Does VLTO Give Us Pause?
- Muted 4.6% annual revenue growth over the last five years shows its demand lagged behind its industrials peers
- Estimated sales growth of 6.5% for the next 12 months is soft and implies weaker demand
At $98.40 per share, Veralto trades at 21.8x forward P/E. Read our free research report to see why you should think twice about including VLTO in your portfolio.
Repligen (RGEN)
Trailing 12-Month GAAP Operating Margin: 8.2%
With over 13 strategic acquisitions since 2012 to build its comprehensive bioprocessing portfolio, Repligen (NASDAQ: RGEN) develops and manufactures specialized technologies that improve the efficiency and flexibility of biological drug manufacturing processes.
Why Are We Bearish on RGEN?
- Efficiency has decreased over the last five years as its adjusted operating margin fell by 16.2 percentage points
- Earnings per share have contracted by 3.8% annually over the last five years, a headwind for returns as stock prices often echo long-term EPS performance
- Diminishing returns on capital from an already low starting point show that neither management’s prior nor current bets are going as planned
Repligen’s stock price of $179.81 implies a valuation ratio of 79.4x forward P/E. To fully understand why you should be careful with RGEN, check out our full research report (it’s free).
One Stock to Buy:
Limbach (LMB)
Trailing 12-Month GAAP Operating Margin: 5.9%
Established in 1901, Limbach (NASDAQ: LMB) provides integrated building systems solutions, including mechanical, electrical, and plumbing services.
Why Do We Love LMB?
- Annual revenue growth of 15.6% over the last two years was superb and indicates its market share increased during this cycle
- Performance over the past two years shows its incremental sales were extremely profitable, as its annual earnings per share growth of 20% outpaced its revenue gains
- Market-beating returns on capital illustrate that management has a knack for investing in profitable ventures, and its returns are climbing as it finds even more attractive growth opportunities
Limbach is trading at $41.73 per share, or 11.5x forward P/E. Is now the right time to buy? See for yourself in our in-depth research report, it’s free.
Stocks We Like Even More
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.
